NCT06393374

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-06-24Est. Completion: 2030-12-16

Enrollment target: 1,530 participants

Locations

Infirmary Cancer Care ( Site 0001), Mobile, Alabama, United States
Ironwood Cancer & Research Centers-Research ( Site 0054), Chandler, Arizona, United States
MemorialCare Orange Coast Medical Center ( Site 9501), Fountain Valley, California, United States
Scripps Cancer Center ( Site 0052), La Jolla, California, United States
Cancer and Blood Specialty Clinic ( Site 0008), Los Alamitos, California, United States
Kaiser Permanente - Oakland ( Site 0079), Oakland, California, United States
Profound Research LLC ( Site 0105), Oceanside, California, United States
Kaiser Permanente - Roseville ( Site 0081), Roseville, California, United States
Kaiser Permanente - San Francisco ( Site 0080), San Francisco, California, United States
Kaiser Permanente - Santa Clara ( Site 0082), Santa Clara, California, United States
Providence Medical Foundation ( Site 9543), Santa Rosa, California, United States
Kaiser Permanente Vallejo Medical Center ( Site 0060), Vallejo, California, United States
Kaiser Permanente - Walnut Creek ( Site 0078), Walnut Creek, California, United States

Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer…

Gilbert, United StatesEst. completion Mar 23, 2033

Breast CancerBreast CarcinomaCancer of the BreastMalignant Neoplasm of Breast

Background: Breast cancer is the most common cancer among women. It can often spread to the liver, lungs, bones, or bra…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.